MARKET

DARE

DARE

Dare Bioscience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.040
-0.020
-1.89%
After Hours: 1.070 +0.03 +2.88% 18:38 09/18 EDT
OPEN
1.090
PREV CLOSE
1.060
HIGH
1.100
LOW
1.030
VOLUME
737.90K
TURNOVER
--
52 WEEK HIGH
2.220
52 WEEK LOW
0.6902
MARKET CAP
27.71M
P/E (TTM)
-1.2051
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average DARE stock price target is 5.10 with a high estimate of 7.50 and a low estimate of 3.000.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About DARE
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Dare Bioscience Inc stock information, including NASDAQ:DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DARE stock methods without spending real money on the virtual paper trading platform.